|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 31/40 | (2006.01) |
| A61P 1/06 | (2018.01) | ||
| A61K 31/403 | (2006.01) | ||
| A61P 9/10 | (2018.01) | ||
| A61K 31/4985 | (2006.01) | ||
| A61K 31/351 | (2013.01) | ||
| A61K 31/522 | (2006.01) | ||
| A61K 31/40 | (2013.01) | ||
| A61P 43/00 | (2018.01) | ||
| A61K 31/70 | (2006.01) | ||
| A61K 31/7042 | (2006.01) | ||
| A61P 3/04 | (2018.01) | ||
| A61P 3/10 | (2006.01) | ||
| A61P 3/10 | (2018.01) | ||
| A61K 38/28 | (2006.01) | ||
| A61K 31/155 | (2013.01) | ||
| A61K 31/7042 | (2013.01) | ||
| A61K 31/155 | (2006.01) | ||
| A61K 31/403 | (2013.01) | ||
| A61K 38/28 | (2013.01) | ||
| A61P 3/00 | (2018.01) | ||
| A61K 31/522 | (2013.01) | ||
| A61P 3/06 | (2018.01) | ||
| A61K 38/26 | (2013.01) | ||
| A61K 31/70 | (2013.01) | ||
| A61K 31/4985 | (2013.01) |
| (11) | Number of the document | 3142661 |
| (13) | Kind of document | T |
| (96) | European patent application number | 15726257.7 |
| Date of filing the European patent application | 2015-05-14 | |
| (97) | Date of publication of the European application | 2017-03-22 |
| (45) | Date of publication and mention of the grant of the patent | 2021-10-06 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/GB2015/051437 |
| Date | 2015-05-14 |
| (87) | Number | WO 2015/173584 |
| Date | 2015-11-19 |
| (30) | Number | Date | Country code |
| 201461994222 P | 2014-05-16 | US | |
| 201462011084 P | 2014-06-12 | US |
| (72) |
HIRSHBERG, Boaz , US
IQBAL, Nayyar , US
|
| (73) |
Astrazeneca AB ,
151 85 Södertälje,
SE
|
| (54) | METHOD FOR SUPPRESSING GLUCAGON SECRETION OF AN SGLT2 INHIBITOR |
| METHOD FOR SUPPRESSING GLUCAGON SECRETION OF AN SGLT2 INHIBITOR |